<code id='81FD76E54A'></code><style id='81FD76E54A'></style>
    • <acronym id='81FD76E54A'></acronym>
      <center id='81FD76E54A'><center id='81FD76E54A'><tfoot id='81FD76E54A'></tfoot></center><abbr id='81FD76E54A'><dir id='81FD76E54A'><tfoot id='81FD76E54A'></tfoot><noframes id='81FD76E54A'>

    • <optgroup id='81FD76E54A'><strike id='81FD76E54A'><sup id='81FD76E54A'></sup></strike><code id='81FD76E54A'></code></optgroup>
        1. <b id='81FD76E54A'><label id='81FD76E54A'><select id='81FD76E54A'><dt id='81FD76E54A'><span id='81FD76E54A'></span></dt></select></label></b><u id='81FD76E54A'></u>
          <i id='81FD76E54A'><strike id='81FD76E54A'><tt id='81FD76E54A'><pre id='81FD76E54A'></pre></tt></strike></i>

          entertainment

          entertainment

          author:entertainment    Page View:81

          Can the FDA be too flexible? How do you test a mechanical womb? And who decides what’s good enough for patients in need?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Lizzy Lawrence joins us to explain the promise of artificial wombs and the debate over how to ethically develop them. We also discuss a momentous upcoming meeting in which FDA will consider the thorny case of a potential medicine for ALS whose supporting evidence has polarized patients and physicians.

          advertisement

          For more on what we cover, here’s the latest on artificial womb technology; here’s more on the ALS debate; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          focus

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Eli Lilly buys Point Biopharma in radiopharmaceuticals play
          Eli Lilly buys Point Biopharma in radiopharmaceuticals play

          DarronCummings/APAcouplebillionhere,acouplebillionthere,andprettysoonEliLillyhopesitwillbetalkingabo

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          Why age limits for politicians are a terrible idea

          AdobeArecentpollfromYouGov/CBSNewsshowedthat77%ofrespondentssaidthatthereshouldbeamaximumagelimitfor